Oncology news
72 views | +0 today
Follow
Oncology news
Latest product, company and treatment news on oncology
Curated by IpsosHEC
Your new post is loading...
Your new post is loading...
Scooped by IpsosHEC
Scoop.it!

IVF in young women tied to breast cancer: study - Reuters

IVF in young women tied to breast cancer: study - Reuters | Oncology news | Scoop.it
ABC OnlineIVF in young women tied to breast cancer: studyReuters(Reuters) - Women who go through in vitro fertilization (IVF) early in life are at a higher risk of developing breast cancer compared to those who don't undergo ...Exercising Often May...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Moderate Exercise Can Lower Breast Cancer Risk: Study

Moderate Exercise Can Lower Breast Cancer Risk: Study | Oncology news | Scoop.it
Just a little bit of exercise is enough to decrease the risk of breast cancer, according to a new study. However, University of North Carolina in Chapel Hill researchers said that the best way to lower your risk of breast cancer is ...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Montefiore Studies Discover "Sandwich" Therapy Best Treatment ... - MarketWatch (press release)

Montefiore Studies Discover "Sandwich" Therapy Best Treatment ...MarketWatch (press release)Dr.
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Yoga Helps Cancer Patients

Yoga Helps Cancer Patients | Oncology news | Scoop.it
Two new studies find that can doing yoga aids cancer patients in dealing with side effects of medication, improves memory, and reduces pain and other symptoms.
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Researchers: Darwin's principles say cancer will always evolve to ...

Researchers: Darwin's principles say cancer will always evolve to ... | Oncology news | Scoop.it
According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which ...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Study links gum disease, HPV-status of head and neck cancer - University at Buffalo Reporter

Study links gum disease, HPV-status of head and neck cancer - University at Buffalo Reporter | Oncology news | Scoop.it
MD News (press release)Study links gum disease, HPV-status of head and neck cancerUniversity at Buffalo ReporterComments.
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

OXiGENE In-Licenses Rights to Promising Program for ... - MarketWatch (press release)

OXiGENE In-Licenses Rights to Promising Program for ...MarketWatch (press release)An additional 3000 neuroendocrine tumors (NETs) are diagnosed annually.
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Why Novartis Leads The Way In Oncology Research - Seeking Alpha

Why Novartis Leads The Way In Oncology Research - Seeking Alpha | Oncology news | Scoop.it
#oncology Why Novartis Leads The Way In Oncology Research http://t.co/PGxLrnNd...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Honokiol - Complementary Oncology Reports

Honokiol - Complementary Oncology Reports | Oncology news | Scoop.it
The bioactive constituents isolated from the bark of Magnolia officinalis such as magnolol, honokiol and obovatol have anti-inflammatory properties through the inactivation of NF-kappaB which is an important factor in the ...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Breast Cancer Among Men Often More Deadly | Global Pharma ...

Breast Cancer Among Men Often More Deadly | Global Pharma ... | Oncology news | Scoop.it
A new research suggests that breast cancer in men is much less common than it is in women, but it may be more deadly. Men with breast cancer don't do as well.
more...
Marianne Paterson's curator insight, January 16, 2014 1:43 PM

interesting article....

Scooped by IpsosHEC
Scoop.it!

Celgene Withdraws EU Application for Cancer Drug - Wall Street Journal

Celgene Withdraws EU Application for Cancer Drug - Wall Street Journal | Oncology news | Scoop.it
Proactive Investors USA & CanadaCelgene Withdraws EU Application for Cancer DrugWall Street JournalCelgene withdrew its application to widen use of its blood-cancer drug Revlimid after European regulators raised questions about the treatment's links...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Multiple sclerosis patients have lower risk of cancer: research

Multiple sclerosis patients have lower risk of cancer: research | Oncology news | Scoop.it
Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health.
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Task force recommends new lung cancer screening guidelines

Task force recommends new lung cancer screening guidelines | Oncology news | Scoop.it
A lung screening and surveillance task force, established by the American Association for Thoracic Surgery (AATS) and led by medical professionals from Brigham and Women's Hospital (BWH), is strongly recommending new ...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Celebrex-Derived Drug Targets Common Childhood Bone Tumor - Newswise (press release)

Celebrex-Derived Drug Targets Common Childhood Bone TumorNewswise (press release)Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, ...
more...
No comment yet.
Scooped by IpsosHEC
Scoop.it!

Roche's breast cancer drug extends survival in study - Reuters

Roche's breast cancer drug extends survival in studyReutersZURICH, June 22 (Reuters) - A late-stage study showed thatwomen with an aggressive type of breast cancer livedsignificantly longer when treated with Roche's ...Genentech Says Perjeta Combination...
more...
No comment yet.